Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Feb 13, 2019	An amendment to the SC 13G filing	SC 13G/A	View HTML 0000315066-19-001407.pdf 0000315066-19-001407.rtf
Feb 13, 2019	Registration of up to an additional 20% of securities for any offering registered on an S-1	S-1MEF	View HTML 0001193125-19-038611.pdf 0001193125-19-038611.rtf 0001193125-19-038611.xls
Feb 13, 2019	EFFECT	EFFECT	View HTML 9999999995-19-000241.pdf 9999999995-19-000241.rtf 9999999995-19-000241.xls
Feb 12, 2019	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001193805-19-000204.pdf 0001193805-19-000204.rtf 0001193805-19-000204.xls
Feb 12, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0001193805-19-000209.pdf 0001193805-19-000209.rtf 0001193805-19-000209.xls
Feb 11, 2019	Registration statement for face-amount certificate companies	S-1	View HTML 0001193125-19-033935.pdf 0001193125-19-033935.rtf 0001193125-19-033935.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Feb 11, 2019	CORRESP	CORRESP	View HTML 0001193125-19-034089.pdf 0001193125-19-034089.rtf 0001193125-19-034089.xls
Feb 11, 2019	CORRESP	CORRESP	View HTML 0001193125-19-034084.pdf 0001193125-19-034084.rtf 0001193125-19-034084.xls
Feb 08, 2019	Securities offered to employees pursuant to employee benefit plans	S-8	View HTML 0001193125-19-032355.pdf 0001193125-19-032355.rtf 0001193125-19-032355.xls
Feb 08, 2019	UPLOAD	UPLOAD	View HTML 0000000000-19-001649.pdf 0000000000-19-001649.rtf

Data provided by Kaleidoscope.